As much as I love doing research, I feel great aversion doing it at the cost of countless animals being sacrificed. Being a passionate advocate of ethical and sustainable research practices, I am fascinated by the idea of using alternative in vitro platforms to reduce and ultimately replace animal testing methodologies. While I acknowledge the historical significance of animal testing and the complex physiological interactions that they provide, I firmly believe that the rapid advancements in the field of biomedical research and development of in vitro testing platforms such as microphysiological systems, organoids, 3D bioprinting offer a more humane and robust approach for toxicological assessments.
Scientist specialized in 3D biology with hands-on experience in high-throughput screening using physiologically relevant models. During my PhD, I focused on developing and optimizing 3D cell culture assays (such as spheroids, organoids, and 3D colony formation assays) for use in high-throughput settings, gaining strong expertise in assay design and imaging. In my industry role, I contributed to the automation of complex 3D biology workflows, supporting decision-making through advanced imaging and AI-based image analysis. I’ve worked extensively with iPSCs, adult stem cells, and various 3D assay formats, driving innovation at the interface of cell biology, automation, and data science.